PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse Model
Authors
Keywords
T cells, Lymphomas, Mouse models, B cells, Immunohistochemistry techniques, Cancer treatment, Blood, T cell receptors
Journal
PLoS Pathogens
Volume 12, Issue 5, Pages e1005642
Publisher
Public Library of Science (PLoS)
Online
2016-05-18
DOI
10.1371/journal.ppat.1005642
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
- (2015) Lieping Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- (2015) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro
- (2015) Lina Quan et al. PLoS One
- Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity
- (2015) J. David Peske et al. Nature Communications
- Update on checkpoint blockade therapy for lymphoma
- (2015) Justin Kline et al. Journal for ImmunoTherapy of Cancer
- EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy
- (2015) Wenfeng Fang et al. Oncotarget
- Biochemical Signaling of PD-1 on T Cells and Its Functional Implications
- (2014) Vassiliki A. Boussiotis et al. CANCER JOURNAL
- The interplay between Epstein–Barr virus and B lymphocytes: implications for infection, immunity, and disease
- (2014) Olivia L. Hatton et al. IMMUNOLOGIC RESEARCH
- LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis
- (2014) Shi-Dong Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- EBV Latent Membrane Proteins (LMPs) 1 and 2 as Immunotherapeutic Targets: LMP-Specific CD4+ Cytotoxic T Cell Recognition of EBV-Transformed B Cell Lines
- (2014) T. A. Haigh et al. JOURNAL OF IMMUNOLOGY
- Comprehensive molecular characterization of gastric adenocarcinoma
- (2014) Adam J. Bass et al. NATURE
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Somatic Mutations and Immunotherapy Outcome with CTLA-4 Blockade in Melanoma
- (2014) Vassiliki A. Boussiotis NEW ENGLAND JOURNAL OF MEDICINE
- Host genetics of Epstein-Barr virus infection, latency and disease
- (2014) Charlotte J. Houldcroft et al. REVIEWS IN MEDICAL VIROLOGY
- Immunological Dysregulation in Multiple Myeloma Microenvironment
- (2014) Alessandra Romano et al. Biomed Research International
- Checkpoint blocking antibodies in cancer immunotherapy
- (2013) Chrisann Kyi et al. FEBS LETTERS
- Innate and adaptive immune cells in the tumor microenvironment
- (2013) Thomas F Gajewski et al. NATURE IMMUNOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphomas occurring specifically in HIV-infected patients: From pathogenesis to pathology
- (2013) Annunziata Gloghini et al. SEMINARS IN CANCER BIOLOGY
- Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas
- (2013) Ming-Han Tsai et al. Cell Reports
- Peripheral Tissue Homing Receptor Control of Naïve, Effector, and Memory CD8 T Cell Localization in Lymphoid and Non-Lymphoid Tissues
- (2013) C. Colin Brinkman et al. Frontiers in Immunology
- Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy
- (2012) M. R. Green et al. CLINICAL CANCER RESEARCH
- EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
- (2012) Robert E. White et al. JOURNAL OF CLINICAL INVESTIGATION
- B7-H1, Which Represses EBV-Immortalized B Cell Killing by Autologous T and NK Cells, Is Oppositely Regulated by c-Myc and EBV Latency III Program at Both mRNA and Secretory Lysosome Levels
- (2012) S. Durand-Panteix et al. JOURNAL OF IMMUNOLOGY
- Early Age at Time of Primary Epstein–Barr Virus Infection Results in Poorly Controlled Viral Infection in Infants From Western Kenya: Clues to the Etiology of Endemic Burkitt Lymphoma
- (2012) Erwan Piriou et al. JOURNAL OF INFECTIOUS DISEASES
- Holoendemic Malaria Exposure Is Associated with Altered Epstein-Barr Virus-Specific CD8+T-Cell Differentiation
- (2012) Pratip K. Chattopadhyay et al. JOURNAL OF VIROLOGY
- An Epstein-Barr Virus (EBV) Mutant with Enhanced BZLF1 Expression Causes Lymphomas with Abortive Lytic EBV Infection in a Humanized Mouse Model
- (2012) S.-D. Ma et al. JOURNAL OF VIROLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hodgkin Lymphoma in Patients with HIV Infection: A Review
- (2012) Nihal Martis et al. Current Hematologic Malignancy Reports
- A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
- (2011) Omid Hamid et al. Journal of Translational Medicine
- Exhausted Cytotoxic Control of Epstein-Barr Virus in Human Lupus
- (2011) Martin Larsen et al. PLoS Pathogens
- Lymphomas differ in their dependence on Epstein-Barr virus
- (2010) D. T. Vereide et al. BLOOD
- The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disorders
- (2010) A. Merlo et al. HAEMATOLOGICA
- Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10
- (2010) M. Rodriguez-Garcia et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas
- (2010) S.-D. Ma et al. JOURNAL OF VIROLOGY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
- (2009) Till Strowig et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cyclical Expression of EBV Latent Membrane Protein 1 in EBV-Transformed B Cells Underpins Heterogeneity of Epitope Presentation and CD8+ T Cell Recognition
- (2009) J. M. Brooks et al. JOURNAL OF IMMUNOLOGY
- T Cell–Mediated Control of Epstein‐Barr Virus Infection in Humanized Mice
- (2009) Misako Yajima et al. JOURNAL OF INFECTIOUS DISEASES
- Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients
- (2008) N. Asano et al. BLOOD
- HIV-associated lymphomas and gamma-herpesviruses
- (2008) A. Carbone et al. BLOOD
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search